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Background: To evaluate the serum level of the local anesthetic mepivacaine 3% without vasoconstrictor in pa-
tients who underwent procedures performed in the anterior and posterior maxilla, through a method of possible 
extraction to quantify it in human plasma by high performance liquid chromatography (HPLC). 
Material and Methods: This was a hybrid study consisting of 18 patients (7 females and 11 males) classified as 
ASA I, adults and with normal body mass index, submitted to procedures in the anterior region (group I) and pos-
terior region of the maxilla (group II). For 40 minutes, five 6 ml blood samples were collected every 10 minutes 
after infiltrative injection in each region of the maxilla. Serum levels of the drug were obtained through HPLC. 
Blood pressure (BP) and heart rate (HR) were measured throughout the procedure. 
Results: When compared to the general average of the concentrations of each group, significant values (p <0.05) 
with greater absorption were observed for the anterior region of the maxilla (group I). There was no significant 
difference when comparing blood pressure (BP) and heart rate (HR) values. 
Conclusions: The concentrations found are safe for infiltrative anesthesia in the analyzed patients, there was a 
higher plasma level of the local anesthetic in the anterior region of the maxilla and there was no change in HR and 
BP in relation to the anesthetized area.
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Introduction
Local anesthesia is a way to numb a specific area of the 
body so that a medical procedure can be done without 
causing pain. Some operations, many dental procedures, 
and different types of diagnostic tests can be done using 
local anesthesia alone (1). 
Many variables influence the absorption of anesthetic 
sites. These include the affinity of the anesthetic for the 
local tissues, tissue blood flow, the effect of the anes-
thetic on the local circulation, and the co-administra-
tion of a vasoconstrictor. In general, drugs injected for 
dental anesthesia are absorbed very rapidly, with maxi-
mal plasma concentrations occurring within 15 to 30 
minutes (2). 
The amount of local anesthetic that enters the systemic 
circulation and its potency determines the systemic 
toxicity of the agent. Ideally, systemic absorption is 
minimized to avoid unnecessary toxicity. The vascular-
ity of the injection site, the concentration of the drug, 
the addition of a vasoconstrictor and the properties of 
the injected solution (such as its viscosity) influence the 
speed and extent of systemic absorption of local anes-
thetics (3). 
To analyze the absorption of the local anesthetic in hu-
man plasma, it is convenient to use a simple, precise 
analytical method with high detection power for the 
drug in low concentration in human plasma (4). One of 
the best methods to identify the plasmatic level of local 
anesthetics is high performance liquid chromatography. 
This is used for the identification of compounds, by 
comparison with previously existing standards, for the 
purification of compounds, by separating the undesir-
able substances and for separating the components from 
a mixture (5). 
There is in the literature a scarcity of studies assessing 
the plasmatic level of local anesthetics considering the 
maxillofacial anatomical area. Regarding mepivacaine 
there is no published study. The goal of this paper is to 
determine if the anesthetic infiltration in two distinct 
anatomical regions can influence the concentration of 
the plasmatic level of the local anesthetic mepivacaine.
Material and Methods
-Study Design and Sample Selection
To contemplate the objectives of the research, a 
clinical trial with dependent samples was prepared. 
After approval by the Ethics Committee (CAAE 
33123014.6.0000.5207), 22 patients of both genders and 
aged between 22 to 28 years were selected for the re-
search, with only 18 completing all phases of the study. 
The patients were to be classified as physical status 
ASA I, need for dental procedures in the anterior and 
posterior region of the maxilla in two distinct moments 
(Fig. 1). All patients had their body mass index (BMI) 
within the normal range. Three 3% mepivacaine tubes 
without vasoconstrictor were used for each procedure 
performed respecting the limit dose.
-Blood sample and analysis of Mepivacaine
Five samples of venous blood were collected for local 
anesthetic dosing in each procedure at the following 
time intervals: 0 (prior to local anesthetic administra-
tion), 10, 20, 30 and 40 minutes after administration. 
Fig. 1: Study flowchart.
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Plasma concentration analyzes of local anesthetics were 
performed by high performance liquid chromatography 
(HPLC), performed in chromatograph of the Alliance 
model and the brand Waters brand with e2695 Sunfire 
module. The local anesthetic mepivacaine was extracted 
from the plasmatic level by a modification of the Tanaka 
method (6). The differential of the technique was that 
we used a modern method for suspending the plasma 
samples, while the Tanaka (6) method used a water bath 
to make the suspension, a time consuming and difficult 
to control method, we used the freeze-drying process. 
This is a technology for drying which involves the re-
moval of the liquid through sublimation, that is, all of 
the liquid in the samples were frozen under vacuum, 
sublimated and removed, leaving only the powder, from 
which mepivacaine was dosed. Patients were monitored 
for heart rate and blood pressure at the same time inter-
vals of blood collection.
Patients who did not return to the second procedure and 
had positive aspirations at the time of puncture were ex-
cluded from the research.
-Statistical treatment
Statistical analysis corresponded to descriptive and in-
ferential analyzes. The descriptive one was presented in 
the form of graphs and charts. And the inferential per-
formed through the BioEstat with the following tests: 
Paired T-Student for the analyzes between groups. The 
level of significance used for alpha was 5% with a beta 
of 80%.
Results
Among the 22 patients selected, only 18, eleven males 
and seven females, were included at the end of the study. 
From each patient 10 samples were processed and ana-
lyzed at T0 / T10 / T20 / T30 and T40’ times, totalizing 
180 blood samples.
The plasma concentrations of mepivacaine collected 
from the patient groups (180 samples) were increasing 
and presented a pattern of proportionality at all mo-
ments. Time 0 (T0) was collected in all patients imme-
diately before local anesthesia to obtain baseline values 
of normality. Table 1 shows that the anterior region of 
the maxilla (group I) presented an increase in plasma 
concentration at times 10, 20, 30 and 40 minutes in re-
lation to the posterior region (group II). There was a 
statistically significant increase (p = 0.01) in the general 
average of plasma concentrations between groups with 
favorable values for group I (anterior of maxilla).
Although the average of diastolic blood pressure pre-
sented a relative discrepancy at 10 and 40 minutes, there 
was no statistically significant difference. The heart 
rate, given by beats / minute, was also measured during 
the procedures performed on each patient. There was 
a slight change in the preoperative frequency (0) and 
in the last analysis time of 40 minutes, however there 
was also no significant difference between the groups 
(Table 2).
Discussion
The literature on plasma concentrations of local anes-
thetics seeks to validate effective methods of extraction 
of the studied drugs, as well as to optimize the process-
ing of analyzes which is slow and difficult to execute. 
There are no papers that have evaluated whether there 
is difference in the absorption of local anesthetics as the 
regions of the face or particularly the different maxil-
lary regions. When it comes to analysis only by high-
performance liquid chromatography, few authors have 
used mepivacaine as the drug of choice for the research 
(4,7,8).
Local anaesthetic related systemic toxicity mainly re-
sults from elevated plasma concentrations of these 
General Average 
(D.P.)
T10 (D.P.) T20 (D.P.) T30 (D.P.) T40 (D.P.)
GROUP I AM (D.P.) 2,431 (1,604) 0,957(1,093) 2,258 (1,448) 2,985 (1,235) 3,525 (1,217)
GROUP II PM (D.P.) 1,905 (1,565) 0,512 (0,941) 1,677 (1,491) 2,444 (1,212) 3,045 (1,098)
                      P1 0,01 p¹ 0,24 p¹ 0,40 p¹ 0,17 p¹ 0,12
Table 1: General average (D.P.) of plasma concentrations (µg/ml) and in times 10, 20, 30 e 40 minutes.
P1: Paired T- Student test for analysis between groups.
AM: anterior of the maxilla
PM: posterior of the maxilla
T0: prior to local anesthetic administration
T20: 20 min after administration
T30: 30 min after administration
T40: 40 min after administration
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T0 T10 T20 T30 T40
GROUP I (AM) SYSTOLIC BP† 126 124 124 121 125
DIASTOLIC BP† 74 76 72 71 75
HEART RATE‡ 78 76 75 78 78
GROUP II (PM) SYSTOLIC BP† 124 123 125 122 127
DIASTOLIC BP† 73 72 73 72 70
















Table 2: Average of the measurements of systolic and diastolic blood pressure (BP) and heart (HR) rate in groups I and II in the inter-
vals of 0, 10, 20, 30 and 40 minutes.
AM: anterior of the maxilla
PM: posterior of the maxilla
BP: blood pressure
T0: prior to local anesthetic administration
T20: 20 min after administration
T30: 30 min after administration
T40: 40 min after administration
¹Diastolic BP GI vs Diastolic BP GII
²Systolic BP GI vs Systolic BP GII
³HR GI vs HR GII
Paired T-Student test for analysis between groups
† Measurement in mmHg
‡ Measurement in beats / minute
drugs. It is noted that in adult patients mepivacaine in-
duces toxicity when blood concentrations are above 5.0 
µg/mL. However, routine dental injection is not expect-
ed to reach blood concentrations of this magnitude (9).
The chosen methodology was created by Tanaka et al. 
(6) who developed an effective method for simultane-
ous analysis of bupivacaine, ropivacaine, mepivacaine 
and drugs belonging to the pipecoxylidide group by 
liquid chromatography. This paper was an analysis of 
mepivacaine only, since the objective was to compare 
if there was difference of absorption in the anterior and 
posterior region of the maxilla. The sensitive and selec-
tive method offers the opportunity for the simultaneous 
screening and quantification, for clinical and forensic 
purposes, of almost all local anesthetics (10).
Studies have demonstrated retention times of 4.6 min-
utes for mepivacaine (6). Retention time is a variable of 
the equipment that can be influenced by the pressure of 
the apparatus, the mobile phase used as well as the tem-
perature. A research on liquid chromatography coupled 
to mass spectrometry (LC-MS-MS) observed a reten-
tion time of 4.2 minutes (7). As for Murtaza et al. (11) 
the time was 8 minutes, similar value to ours, 8.69 min-
utes. Highlighting the diversity of time found in each 
study even for the same drug.
In our research, a pilot study was carried out with 6 pa-
tients. In these patients, samples were collected after 60 
minutes of infiltrative anesthesia and blood concentra-
tion decreased was verified. In addition, other studies 
had already reported maximum peak of local anesthetic 
between 20 and 30 minutes (6,12,13).
The maximum concentration of mepivacaine was 4.93 
μg/ml for a patient in group I - anterior region of the 
maxilla - group in which there was greater absorption 
of the anesthetic. This concentration is below the onset 
of toxicity described by Becker and Reed2 for lidocaine 
which is 5 μg/ml, and the convulsive seizures require 
doses above 10 μg/ml to start, and despite of being dif-
ferent anesthetic bases, it is currently used as a refer-
ence for all anesthetics. There are no studies that have 
demonstrated the minimal concentration of toxicity to 
mepivacaine in healthy patients. However, a study con-
ducted by Tanoubi et al. (14), found a toxicity onset in 
a 54-year-old patient who presented agitation and ar-
rhythmia with a mepivacaine level of 5.1 μg/ml, but the 
patient had chronic renal failure and was not a param-
eter for healthy patients in this research. In surgery for 
the removal of the four third molars using 6 anestubes 
of mepivacaine 2% with adrenaline 1:100.000 it was 
possible to detect 7.72 μg/ml for a healthy 59 kg patient 
without showing any signs of toxicity either in the ner-
vous or cardiovascular system (3).
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In both groups of our study, infiltrative anesthesia was 
performed, although the intention of anesthesia in the 
posterior region was the execution of the high tuberos-
ity technique, maxillary nerve anesthesia was not ob-
served, since the patients did not report loss of sensi-
tivity of the infraorbital region. In the anterior region, 
infiltrative anesthesia was performed, but the volume of 
anesthetic was also distributed in the nasal region, and 
patients reported a significant loss of sensation in this 
region, reporting anesthesia of the nasal apex.
Thus, we can assume that there was greater absorption 
in the anterior region due to the high vascularization of 
the nasal region (presence of the Kiesselbach plexus), 
and although the posterior region has large vessels, an-
esthesia was performed at the second molar level, dis-
tant from the pterygoid plexus present in a more posteri-
or region, which may justify this increase in absorption. 
Although we used an anesthetic without vasoconstric-
tor, the values of BP and HR were measured, since the 
monitoring of the vital signs brings greater safety for 
both the professional and the patient. Maia (11) used 2% 
mepivacaine with adrenaline 1:100.000 to remove two 
and four third impacted molars, using 3 and 6 anestubes 
respectively. The influence of anesthetic concentration 
with heart rate and blood pressure was evaluated, statis-
tically significant values were only observed in systolic 
BP 40 minutes after anesthetic infiltration for patients 
who received 6 anestubes, while diastolic BP remained 
statistically unchanged as our study. 
Thus, for clinical purposes in dental practice, for ex-
ample, performing an impacted upper canine surgery 
requires a greater caution regarding the use of higher 
volumes of the anesthetic when compared to surgery for 
impacted third molar removal. 
The results of the concentrations found are safe for pa-
tients classified as ASA I, adult and body mass index 
within normal, provided there is no intravascular injec-
tion of the anesthetic of choice. Thus, this study empha-
sizes that professionals should be cautious when anes-
thetizing pediatric patients, for example, in which lower 
doses should be used, especially when interventions are 
performed in the anterior region of the maxilla, which 
revealed greater absorption. However, researches with 
a larger sample should be performed to confirm if there 
are significant differences.
Conclusions
When the absorption of 3% mepivacaine without vaso-
constrictor in the anterior and posterior regions of the 
maxilla were compared, it was observed that there is a 
greater absorption of the anesthetic in the anterior region. 
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